Need professional-grade analysis? Visit stockanalysis.com
$14.57B
N/A
N/A
438.00%
Price Chart
Risk-Adjusted Performance
Jafron Biomedical Co Ltd (300529) Price Performance
Jafron Biomedical Co Ltd (300529) trades on SHE in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY18.25, down 3.49% from the previous close.
Over the past year, 300529 has traded between a low of CNY18.25 and a high of CNY25.76. The stock has lost 28.2% over this period. It is currently 29.2% below its 52-week high.
Jafron Biomedical Co Ltd has a market capitalization of $14.57B and a dividend yield of 438.00%.
About Jafron Biomedical Co Ltd
Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Company Info
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $2.04B
- EBITDA
- $736.68M
- Profit Margin
- 23.64%
- EPS (TTM)
- 0.65
- Book Value
- 4.43
Technical Indicators
- 52 Week High
- CN¥26.02
- 52 Week Low
- CN¥18.22
- 50 Day MA
- CN¥20.00
- 200 Day MA
- CN¥21.43
- Beta
- 0.43
Valuation
- Trailing P/E
- 28.08
- Forward P/E
- 10.86
- Price/Sales
- 7.15
- Price/Book
- 4.12
- Enterprise Value
- $13.08B